FTC Sees Red Flags In Studies Conducted Overseas To Support Claims

The Federal Trade Commission is wary of studies conducted overseas used to substantiate claims for supplements, says Richard Cleland, assistant director of advertising practices.

More from Archive

More from Pink Sheet